Junhu Wan Selected Research

Colonic Neoplasms (Colon Cancer)

10/2018	HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression.
1/2018	Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junhu Wan Research Topics

Disease

23	Neoplasms (Cancer) 02/2024 - 12/2016
8	Esophageal Squamous Cell Carcinoma 01/2023 - 06/2018
4	Carcinogenesis 01/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
3	Glioma (Gliomas) 12/2023 - 01/2021
3	Adenocarcinoma of Lung 11/2021 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2023
2	Stomach Neoplasms (Stomach Cancer) 12/2023 - 01/2023
2	Microsatellite Instability 07/2023 - 06/2022
2	Endometrial Neoplasms (Endometrial Cancer) 07/2023 - 06/2022
2	Carcinoma (Carcinomatosis) 01/2021 - 03/2019
2	Colonic Neoplasms (Colon Cancer) 10/2018 - 01/2018
1	Pathologic Processes 02/2024
1	Glioblastoma (Glioblastoma Multiforme) 06/2023
1	Circulating Neoplastic Cells 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Nasopharyngeal Carcinoma 01/2023
1	Hypoxia (Hypoxemia) 06/2022
1	Papillary Thyroid Cancer 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 11/2019
1	Hepatocellular Carcinoma (Hepatoma) 03/2019
1	Ovarian Neoplasms (Ovarian Cancer) 02/2019
1	Type 2 Diabetes Mellitus (MODY) 02/2019
1	Deafness (Deaf Mutism) 08/2014

Drug/Important Bio-Agent (IBA)

15	Long Noncoding RNAIBA 12/2023 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2016
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2018
4	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2023 - 01/2023
2	Temozolomide (Temodar)FDA LinkGeneric 06/2023 - 01/2021
2	Circular RNAIBA 01/2023 - 12/2022
2	Antisense RNA (Anti-Sense RNA)IBA 01/2023 - 01/2019
2	Sirtuin 1IBA 01/2023 - 08/2019
2	CateninsIBA 01/2022 - 01/2019
2	6-methyladenineIBA 11/2021 - 01/2021
2	Lysine (L-Lysine)FDA Link 11/2019 - 03/2019
1	5-Methylcytosine (5 Methylcytosine)IBA 02/2024
1	TransferasesIBA 02/2024
1	m(5)C rRNA methyltransferaseIBA 02/2024
1	LigandsIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	SolutionsIBA 01/2023
1	Insulin-Like PeptidesIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	gamma-Butyrobetaine DioxygenaseIBA 01/2022
1	SB 225002IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Competitive Endogenous RNAIBA 08/2020
1	Sincalide FDA Link 01/2020
1	theasinensin AIBA 03/2019
1	Metformin (Glucophage)FDA LinkGeneric 02/2019
1	Glucose (Dextrose)FDA LinkGeneric 02/2019
1	Histones (Histone)IBA 01/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Untranslated RNA (Noncoding RNA)IBA 01/2019
1	NucleotidesIBA 01/2019
1	ApoferritinsIBA 10/2018
1	NF-kappa B (NF-kB)IBA 10/2018
1	LuciferasesIBA 10/2018
1	Small Nucleolar RNA (snoRNA)IBA 01/2018
1	Myosin VIIaIBA 08/2014

Therapy/Procedure

3	Therapeutics 01/2024 - 11/2021
3	Immunotherapy 07/2023 - 06/2022